Work

Hyperpigmented rash of imatinib

Year: 2025

Type: article

Abstract: Imatinib is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia. Inhibition of c-kit causes melanocyte dysfunction, thereby leading to dermatological side effects. It causes various skin side effects and hypopigmented rash being common. We report a rare case of a hyperpigmented rash of Imatinib.

Source: International Journal of Molecular and Immuno Oncology

DOI: 10.25259/ijmio_5_2025

Authors: Karan Sood, Pratiksha Tyagi

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4416565668

FWCI:

Cites: 10

Cited by:

Related to: